Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)

SHE:002864 Revenue

Shaanxi Panlong Pharmaceutical Group Limited By Share had revenue of 222.54M CNY in the quarter ending March 31, 2026, a decrease of -11.06%. This brings the company's revenue in the last twelve months to 1.11B, up 9.79% year-over-year. In the year 2025, Shaanxi Panlong Pharmaceutical Group Limited By Share had annual revenue of 1.14B with 17.15% growth.

• Revenue (ttm): 1.11B
• Revenue Growth: +9.79%
• P/S Ratio: 2.88
• Revenue / Employee: 1.19M
• Employees: 933
• Market Cap: 3.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.14B	167.01M	17.15%
Dec 31, 2024	973.86M	-6.96M	-0.71%
Dec 31, 2023	980.83M	6.53M	0.67%
Jan 1, 2023	974.29M	86.81M	9.78%
Jan 1, 2022	887.48M	217.17M	32.40%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error